Using electronic health record data from six academic centres, the investigators analyzed 453 adults treated with PCSK9i (evolocumab, alirocumab, or inclisiran) who had Lp(a) measured before and after therapy, and compared them with 6,750 controls not receiving PCSK9i
Is Medicare going to start covering GLP-1s
Semaglutide is a weight loss medication which imitates a naturally occurring hormone known as glucagon-like peptide-1 (GLP-1)
Then, we have something that could be useful to public health
Selenium, W
Antonoff MB, Feldman HA, Mitchell KG, Farooqi A, Ludmir EB, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Sepesi B, Swisher SG , Walsh GL, Gandhi S, Gomez DR, Vaporciyan AA